Jianmin Pharmaceutical Group Co Ltd.SSE: 600976

Announcement on Holding the Performance Briefing for Q3 2024

Oct 12, 2024 · Issued by Jianmin Pharmaceutical Group Co Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 12, 2024

On 6ix: 6ix.com/news/announcement-on-holding-the-performance-briefing-for-q3-2024

Announcement on Holding the Performance Briefing for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Jianmin Pharmaceutical Group Co Ltd. on 6ix

Earlier from Jianmin Pharmaceutical

Announcement on Resolution of the 1st Extraordinary General Meeting in 2024Oct 1, 2024
Announcement on the Second Unlocking of Restricted Stock Involved in the 2022 Restricted Stock Incentive PlanSep 14, 2024
Announcement on Obtaining the Drug Registration CertificateAug 28, 2024
2024 Semi-annual Report Full TextAug 16, 2024
Announcement on Convening Semi-annual Performance Briefing 2024Aug 9, 2024

Later from Jianmin Pharmaceutical

Announcement on Election of Director to Act as ChairmanOct 19, 2024
Notice on Convening the 2nd Extraordinary General Meeting in 2024Nov 27, 2024
Announcement on Inclusion and Renewal of the Company's Products on the Catalogue of Drugs for Basic National Medical Insurance (2024)Nov 29, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024Dec 13, 2024
Announcement on Resolution of the 30th Meeting of the 10th Board of DirectorsDec 18, 2024

All Jianmin Pharmaceutical news releases

Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.

Follow Jianmin Pharmaceutical